Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Triplet therapy shows promise in phase 2 study in chronic lymphocytic leukemia

Matthew Davids, MD, MMSc
September 14, 2021
Dana-Farber researchers find that combining a BCL-2 inhibitor with two other targeted agents is active in previously untreated CLL patients A clinical research team led by Dana-Farber Cancer Institute reports that a combination of three molecularly targeted drugs is active against chronic...
Read Story
  • Explore the Newsroom and Our Publications

    News Releases

    See our news releases about cancer care, cancer research, and cancer treatment by Dana-Farber Cancer Institute doctors and researchers.

    News Coverage

    See the latest news about Dana-Farber Cancer Institute.

    For Journalists

    Dana-Farber welcomes the opportunity to partner with journalists. Find contacts, resources, and more.

    News Videos

    Watch brief videos focusing on science, research, and advances in cancer, featuring Dana-Farber Cancer Institute doctors and researchers.

    Publications

    Read the latest issues of Dana-Farber publications, including Paths of Progress and Turning Point.

    Insight Blog

    Insight features the latest in cancer care and research news from Dana-Farber.

    Dana-Farber Spotlight

    Sign up to receive Dana-Farber Spotlight, our email newsletter.
    View sample issue
    Subscribe now
    Unsubscribe from mailings

    Unraveled: A Science Podcast

    Unraveled is a podcast produced by Dana-Farber that explores the mysteries of the science of cancer and the cutting-edge science that is transforming cancer research
  • View Our Events Calendar

    View Dana-Farber's calendar of events, including nutrition seminars, health and wellness classes, patient education, community outreach and fundraising events, and support groups.

    caregiver support group


    Participants in a caregiver support group